Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus

Somatostatin analogs mantain their major role in the treatment of patients with advanced neuroendocrine tumors (NETs) and have multiple modulatory effects on the immune system. Here, we evaluated the effects of lanreotide treatment on expression of Th1, Th2 cytokine patterns in serum of patients wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Sciammarella, Concetta, Luce, Amalia, Riccardi, Ferdinando, Mocerino, Carmela, Modica, Roberta, Berretta, Massimiliano, Misso, Gabriella, Cossu, Alessia Maria, Colao, Annamaria, Vitale, Giovanni, Necas, Alois, Fedacko, Jan, Galdiero, Marilena, Correale, Pierpaolo, Faggiano, Antongiulio, Caraglia, Michele, Capasso, Anna, Grimaldi, Anna
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379869/
https://ncbi.nlm.nih.gov/pubmed/32766136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01047
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge